Abstract：The applications of the crystallization technique in the pharmaceutical industry as a purification and separation process for the isolation and synthesis of pure active pharmaceutical ingredients (API), co-crystals, controlled release pulmonary drug delivery, and separation of chiral isomers are briefly discussed using a few case studies. The effect of process variables and solvent on the polymorphism and morphology of stavudine is discussed. The implementation of external control in the form of feedback and real-time optimal control using cooling and antisolvent crystallization of paracetamol in water-isopropyl alcohol is introduced. Two methods to prepare micron-sized drug particles, namely, micro-crystallization and polymer-coated API-loaded magnetic nanoparticles for pulmonary drug delivery, are discussed. The significance of co-crystals in drug administration is highlighted using the theophylline-nicotinamide co-crystal system. Resolution of chloromandelic acid derivatives, a racemic compound, is achieved using direct crystallization and diastereomeric salts crystallization. The crystal structures of diastereomeric salts of chloromandelic acid and phenylethylamine are determined. The structure comparison between the less soluble and more soluble salts shows that weak interactions such as CH/π interactions and van der Waals forces contribute to chiral recognition when the hydrogen bonding patterns are similar.
出版日期: 2010-03-05
引用本文:
. Applications of the crystallization process in
the pharmaceutical industry[J]. Front. Chem. Sci. Eng., 2010, 4(1): 2-9.
Sohrab ROHANI. Applications of the crystallization process in
the pharmaceutical industry. Front. Chem. Sci. Eng., 2010, 4(1): 2-9.
McKie D, McKie C. Essentials of Crystallography. London: BlackwellScientific Publications, 1986
Mullin J. Crystallization. 3rd ed. London: Butterworth-Heinemann, 1993
Rohani S, Horne S, Murthy K S K. Control of the product quality in batch crystallizationof pharmaceuticals and fine chemicals. Part 1: design of the crystallizationprocess and the effect of solvent. OrgRes Proc Dev, 2005, 9(6): 858–872 doi: 10.1021/op050049v
Rohani S, Horne S, Murthy K S K. Control of the product quality in batch crystallizationof pharmaceuticals and fine chemicals. Part 2: external control. Org Res Proc Dev, 2005, 9(6): 873–883 doi: 10.1021/op050050u
Mirmehrabi M, Rohani S, Murthy K S K, Radatus B. Polymorphic behaviour and crystal habit of an anti-viral/HIV drug:stavudine. J Crystal Growth & Des, 2006, 6(1): 141–149
Skonezny P M, Eisenreich E, Stark D R, Boyhan B T, Baker S R. Process for large scale preparation of 2',3'-didehydro-2',3'-dideonucleosides. EP patent 0653435A1, 1995
Radatus B K, Murthy K S K. Process for the preparationof substantially pure stavudine and related intermediates useful inthe preparation thereof. USA patent 6635753B1, 2003
Mirmehrabi M, Rohani S. An approach to solvent screeningfor crystallization of polymorphic pharmaceuticals and fine chemicals. J Pharm Sci, 2005, 94 (7): 1560–1576 doi: 10.1002/jps.20371
Lu J, Rohani S. Preparation and characterizationof theophylline-nicotinamide co-crystal. Org Proc Res Dev, 2009, 13(6), 1269– 1275 doi: 10.1021/op900047r
Jones A G, Mullin J W. Programmed cooling crystallizationof potassium sulphate solutions. Chem EngSci, 1974, 29, 105–118 doi: 10.1016/0009-2509(74)85036-0
Matthews H B, Rawlings J B. Batch crystallization ofa photochemical: modeling, control, and filtration. AIChE J, 1998, 44: 1119–1127 doi: 10.1002/aic.690440510
Chung S H, Ma D L, Braatz R D. Optimal seeding in batch crystallization. Can J Chem Eng, 1999, 77: 590–596 doi: 10.1002/cjce.5450770322
Hu Q, Rohani S, Wang D X, Jutan A. Nonlinearkinetic parameter estimation for batch cooling seeded crystallization. AIChE J, 2004, 50(8): 1786–1794 doi: 10.1002/aic.10163
Sheikhzadeh M, Trifkovic M, Rohani S. Adaptive MIMO neuro-fuzzy logic control of a seeded andan unseeded anti-solvent semi-batch crystallizer, 2008. Chem Eng Sci, 63(5): 1261–1272 doi: 10.1016/j.ces.2007.07.022
Zhang G, Rohani S. On-line optimal control ofa seeded batch crystallizer. Chem Eng Sci, 2003, 58(9): 1887–1896 doi: 10.1016/S0009-2509(03)00021-6
Trifkovic M, Sheikhzadeh M, Rohani S. Multivariable real-time optimal control of a coolingand anti-solvent semi-batch crystallization process, 2008. AIChE J, 2009, 55(10): 2591–2602 doi: 10.1002/aic.11868
Ragab D, Rohani S, Samaha M W, El-Khawas F M, El-Maradny H A. Crystallization of progesteronefor pulmonary drug delivery. J Pharm Sci, 2009, 09-087.R1
Sholl D S, Gellam A J. Developing chiral surfacesfor enantioselective chemical processing. AIChE J2009, 55(10): 2484–2490 doi: 10.1002/aic.12036
Jacques J, Collet A, Wilen S H. Enantiomers, Racemates and Resolutions. New York: Wiley, 1981
He Q, Zhu J, Gomaa H, Jennings M, Rohani S. Identification and characterizationof solid nature of 2-chloromandelic acid. J Pharm Sci, 2009, 98(5): 1835–1844 doi: 10.1002/jps.21560
